The FASLG gene and FasL protein are overexpressed in many cancers, either by cancer cells themselves or by cells constituting the TME, such as regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), cancer-associated fibroblasts (CAFs), and tumor endothelial cells.5 This evidence concerns the gene FASLG and cancer.